The Safety and Effectiveness of Palonosetron Hydrochloride Capsule Was Used to CINV — TSEPHCC  

Nausea and Vomiting Clinical Trial

Official title: Palonosetron Hydrochloride Capsules (Ruoshan ®) Used to Prevent and Control Chemotherapy for Tumor Patients Real World Study on the Safety of Nausea and Vomiting Reduction

Status Recruiting

Clinical Trial Summary

To observe and evaluate the safety and effectiveness of Palonosetron hydrochloride capsule in preventing acute nausea and vomiting caused by moderate emetic chemotherapy; The characteristics of the applicable population, clinical medication and clinical benefits of Palonosetron Hydrochloride Capsules were analyzed.

Clinical Trial Description

At present, as the mainstream antiemetics of CINV, oral administration is the most commonly used method of drug therapy. Clinical studies showed that there was no difference in the efficacy of 5-HT3 receptor antagonist between different administration routes (oral and intravenous). At the same time, because the oral route is the most convenient, oral preparations provide more and more convenient choices for clinicians and patients. To observe and evaluate the safety and effectiveness of Palonosetron hydrochloride capsule in preventing acute nausea and vomiting caused by moderate emetic chemotherapy; The characteristics of the applicable population, clinical medication and clinical benefits of Palonosetron Hydrochloride Capsules were analyzed. ;

Related Conditions & MeSH terms

• Nausea
• Nausea and Vomiting
• Vomiting

• NCT number: NCT05690802
• Study type: Interventional
• Source: Xijing Hospital
• Contact: Liu Hong, master
• Phone: 13709284513
• Email: hongliu1@fmmu.edu.cn
• Status: Recruiting
• Phase: N/A
• Start date: May 16, 2022
• Completion date: May 30, 2029